All the following are indicated in the long-term therapy of children with coronary abnormalities in Kawasaki disease EXCEPT:
Treatment of Kawasaki Disease Acute stage Intravenous immunoglobulin 2 g/kg over 10-12 hr and Aspirin 80-100 mg/kg/day divided every 6 hr orally until patient is afebrile for at least 48 hr Convalescent stage Aspirin 3-5 mg/kg once daily until 6-8 wk after illness onset if normal coronary findings throughout Long-term therapy for patients with coronary abnormalities Aspirin 3-5 mg/kg once daily orally or Clopidogrel 1 mg/kg/day (maximum: 75 mg/day) Warfarin or low-molecular-weight heparin added for patients at paicularly high risk of thrombosis Acute coronary thrombosis Prompt fibrinolytic therapy with tissue plasminogen activator or other thrombolytic agent
Intravenous immunoglobulins
Aspirin
Clopidogrel
Warfarin
Vasculitic Disorders in Children